View Post

Team develops new therapy using magnetic seeds to heat and kill cancer

In In The News by Barbara Jacoby

By: University College London From: medicalxpress.com Scientists at UCL have developed a novel cancer therapy that uses an MRI scanner to guide a magnetic seed through the brain to heat and destroy tumors. The therapy, demonstrated in mice, is called “minimally invasive image-guided ablation,” or MINIMA, and comprises a ferromagnetic thermoseed navigated to a tumor using magnetic propulsion gradients generated …

View Post

MetVital, Inc. Announces FDA Clearance of Investigational New Drug (IND) Application for AEO for Phase 2 testing for Glioblastoma Multiforme

In Clinical Studies News by Barbara Jacoby

From: finance.yahoo.com MetVital, Inc., a biopharmaceutical company developing small molecule modulators of glutamate metabolism for the treatment of diseases with significant unmet medical need and commercial potential, today announces that the U.S. Food and Drug Administration (FDA) has notified MetVital that it may proceed with its clinical investigation of “Anhydrous Enol-Oxaloacetate” (AEO) as a potential treatment for patients with Glioblastoma …

View Post

Researchers Successfully Turn Breast Cancer Cells Into Fat to Stop Them From Spreading

In Clinical Studies News by Barbara Jacoby

By: JACINTA BOWLER From: sciencealert.com Researchers have been able to coax human breast cancer cells to turn into fat cells in a new proof-of-concept study in mice. To achieve this feat, the team exploited a weird pathway that metastasising cancer cells have; their results are just a first step, but it’s a truly promising approach. When you cut your finger, …

View Post

Targeting the engine room of the cancer cell

In In The News by Barbara Jacoby

Source:: Columbia University Irving Medical Center From: sciencedaily.com Researchers at Columbia University Irving Medical Center (CUIMC) have developed a highly innovative computational framework that can support personalized cancer treatment by matching individual tumors with the drugs or drug combinations that are most likely to kill them. The study, published today on Nature Genetics, by Dr. Andrea Califano of Columbia University Irving Medical …